These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7833151)

  • 1. Control of oncogene expression by antisense nucleic acids.
    Hélène C
    Eur J Cancer; 1994; 30A(11):1721-6. PubMed ID: 7833151
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antisense nucleic acids and gene therapy].
    Saison-Behmoaras E
    Bull Cancer; 1995 Mar; 82(3):224-5. PubMed ID: 7655155
    [No Abstract]   [Full Text] [Related]  

  • 3. Better blocker: RNA interference dazzles research community.
    Garber K
    J Natl Cancer Inst; 2003 Apr; 95(7):500-2. PubMed ID: 12671010
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncogene suppression by small interfering RNAs.
    Heidenreich O
    Curr Pharm Biotechnol; 2004 Aug; 5(4):349-54. PubMed ID: 15320765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver?
    Kortylewski M; Nechaev S
    Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical development of antisense oligonucleotides as anti-cancer therapeutics.
    Chen HX
    Methods Mol Med; 2003; 75():621-36. PubMed ID: 12407768
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications.
    Calabretta B
    Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy for cancer.
    Kipps TJ
    J Hematother; 1993; 2(3):367-72. PubMed ID: 7921998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide view of antisense.
    Cho-Chung YS; Becker KG
    Nat Biotechnol; 2003 May; 21(5):492. PubMed ID: 12721568
    [No Abstract]   [Full Text] [Related]  

  • 10. Antisense oncogene and tumor suppressor gene therapy of cancer.
    Zhang WW
    J Mol Med (Berl); 1996 Apr; 74(4):191-204. PubMed ID: 8740650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotides as modulators of cancer gene expression.
    Curcio LD; Bouffard DY; Scanlon KJ
    Pharmacol Ther; 1997; 74(3):317-32. PubMed ID: 9352587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 10 years and counting: the hype and hope of cancer biotechnology.
    Morris K
    Lancet Oncol; 2002 Oct; 3(10):582. PubMed ID: 12372706
    [No Abstract]   [Full Text] [Related]  

  • 13. The prospects for antisense therapy.
    Gewirtz AM
    Hosp Pract (1995); 1999 Sep; 34(10):97-107; quiz 141. PubMed ID: 10901752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense therapy for cancer.
    Gleave ME; Monia BP
    Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense inhibition of oncogene expression.
    Neckers L; Whitesell L; Rosolen A; Geselowitz DA
    Crit Rev Oncog; 1992; 3(1-2):175-231. PubMed ID: 1312868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides.
    Hélène C
    Eur J Cancer; 1991; 27(11):1466-71. PubMed ID: 1835863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Selection of Antisense Oligonucleotides Targeting Transforming Growth Factor Beta (TGF-β) Isoform mRNAs for the Treatment of Solid Tumors.
    Jaschinski F; Korhonen H; Janicot M
    Methods Mol Biol; 2015; 1317():137-51. PubMed ID: 26072406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense strategies for the control of aberrant gene expression.
    Sczakiel G
    J Hematother; 1994; 3(4):305-13. PubMed ID: 7735826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.